ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

RFA Available

January 15, 1999

Support Available For Studies Abroad

August 12, 1983

NCCS Appointment Marks Transition To New Structure.

March 17, 2000